4Takada K,Asada S, Ichikawa Y, et al. Pharmacokinetics of Bredinin in renal transplant patients. Eur J Clin Pharmacol, 1983, 24(4) :457 - 461.
5Nagata T,Nagata T,Aramaki Y,et al. Subacute toxicity test of mizoribine in beagle dogs for 30 days. Appl Pharmacol, 1983,26 (1):327.
6Tanabe K, Tokumoto T, Ishikawa N, et al. Long-term results in mizoribine- treated renal transplant recipients:a prospective, randomized trial of mizoribine and azathioprine under cyclosporine- based immunosuppression. Transplant Proc, 1999, 31(7) :2877 - 2879.
8Yoshidome K, Takei S, Imanaka H, et al. Efficacy of mizoribine in the treatment of systemic lupus erythematosus in children: Pediatr Int,2004,46(4) :444 - 449.
9Kuroda T,Hirose S,Tanabe N,et al. Mizoribine therapy for patients with lupus nephritis: the association between peak mizoribine concentration and clinical efficacy. Mod Rheumatol, 2007,17(3) : 206 - 212.
10Tanaka H, Tsugawa K, Suzuki K, et al. Long - term mizoribine intermittent pulse therapy for young patients with flare of lupus nephritis. Pediatr Nephrol, 2006,21(7) : 962 - 966.
二级参考文献18
1Kusumi T,Tsuda M,Katsumura T,et al.Dual inhibitory effect of Mizoribine.Biochem Funet,1989,7:201-203.
2Nagata T,Nagata T,Aramaki Y,et al.Subacute toxicity test of Mizoribine in beagle dogs for 30 days.Appl Pharmacol,1983,26:327-329.
3Takahashi S,Wakui H,Gustafsson JA,et al.Functional interaction of the immunosuppressant mizoribine with the 14-3-4 proteine.Biochem Biophs Res Cqmmun,2000,274:87-92.
4Shiraki K,Ishibashi M,Okuno T,et al.Effects of cyclosporine,azathioprine,mizoribine,and predinisolone on replication of human cytomegalovirus.Transplant Proc,1990,22:1682-1685.
6Faraj G,Cochat P,Serre-Beauvais F,et al.Mizoribine as an alternative to azothioprine in pediatric renal transplantation.Transplantation,1996,62:1701-1702
7Striker LJ, Doi T, Elliot S, et al. The contribution of glomerular mesangial cells to progressive glomerulosclerosis. Semin Nephrol, 1989, 9: 318-328.
8Pippin JW, Qu Q, Meijer L, et al. Direct in vivo inhibition of the nuclear cell cycle cascade in experimental mesangial proliferative glomerulonephritis with Roscovitine, a novel cyclin-dependent kinase antagonist. J Clin Invest, 1997, 100: 2512-2520.
9Shankland S, Hugo C, Coats S, et al. Changes in cell cycle protein expression during experimental mesangial proliferative glomerulonephritis. Kidney lnt, 1996, 50: 1230-1239.
10Lang S, Hartner A, Sterzel RB, et al. Requirement of cyclin D1 in mesangial cell mitogenesis. J Am Soc Nephrol, 2000, 11 : 1398-1408.
7Tanabe K,Tokumoto T,Ishikawa N,et al.Long-term results in mizoribine-treated renal transplant recipients:a prospective,randomized trial of mizoribine and azathioprine under cyclosporine-based immunosuppression[J].Transplant Proc,1999,31(7):2877.
8Kuroda T,Hirose S,Tanabe N,et al.Mizoribine therapy for patients with lupus nephritis:the association between peak mizoribine concentration and clinical efficacy[J].Mod Rheumatol,2007,17(3):206.
9Tanaka H,Tsugawa K,Suzuki K,et al.Long-term mizoribine intermittent pulse therapy for young patients with flare of lupus nephritis[J].Pediatr Nephrol,2006,21(7):962.
10Shin J,Park J,Shin Y,et al.Can azathioprine and steroids alter the progression of severe Henoch-Schonlein nephritis in children[J].Pediatr Nephrol,2005,20(8):1087.
